- Home
- FBIZ vs IGMS Comparison
FBIZ vs IGMS Comparison
Compare FBIZ & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIZ
- IGMS
- Stock Information
- Founded
- FBIZ 1909
- IGMS 1993
- Country
- FBIZ United States
- IGMS United States
- Employees
- FBIZ N/A
- IGMS N/A
- Industry
- FBIZ Major Banks
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- FBIZ Finance
- IGMS Health Care
- Exchange
- FBIZ Nasdaq
- IGMS Nasdaq
- Market Cap
- FBIZ 380.5M
- IGMS 348.5M
- IPO Year
- FBIZ N/A
- IGMS 2019
- Fundamental
- Price
- FBIZ $46.96
- IGMS $1.71
- Analyst Decision
- FBIZ Strong Buy
- IGMS Hold
- Analyst Count
- FBIZ 4
- IGMS 8
- Target Price
- FBIZ $51.75
- IGMS $6.14
- AVG Volume (30 Days)
- FBIZ 35.1K
- IGMS 783.1K
- Earning Date
- FBIZ 01-30-2025
- IGMS 03-06-2025
- Dividend Yield
- FBIZ 2.14%
- IGMS N/A
- EPS Growth
- FBIZ 6.29
- IGMS N/A
- EPS
- FBIZ 4.64
- IGMS N/A
- Revenue
- FBIZ $140,240,000.00
- IGMS $2,918,000.00
- Revenue This Year
- FBIZ N/A
- IGMS $23.57
- Revenue Next Year
- FBIZ $8.01
- IGMS $192.36
- P/E Ratio
- FBIZ $10.11
- IGMS N/A
- Revenue Growth
- FBIZ 3.59
- IGMS 57.64
- 52 Week Low
- FBIZ $32.56
- IGMS $1.59
- 52 Week High
- FBIZ $52.22
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- FBIZ 54.45
- IGMS 19.36
- Support Level
- FBIZ $44.95
- IGMS $1.59
- Resistance Level
- FBIZ $46.28
- IGMS $2.06
- Average True Range (ATR)
- FBIZ 1.13
- IGMS 0.41
- MACD
- FBIZ 0.28
- IGMS -0.25
- Stochastic Oscillator
- FBIZ 95.12
- IGMS 2.18
About FBIZ First Business Financial Services Inc.
First Business Financial Services Inc operates as a bank holding company. The Bank operates as a business bank, focusing on delivering a full line of commercial banking products including commercial loans and commercial real estate loans, to meet the specific needs of small and medium-sized businesses, business owners, executives, professionals, and high-net-worth individuals. The company's products and services include commercial lending, SBA lending and servicing, asset-based lending, equipment financing, factoring, trust, and investment services, treasury management services, and a broad range of deposit products. Geographically all the business activity functioned through the region of the United States.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.